SPRC

SciSparc Ltd.
CAPPED RATING

SciSparc Ltd. (SPRC) is rated D+ (1.8/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Value (B); its weakest is Momentum (F).

Quantitative Factor Evaluation • Updated

Overall Rating
1.8 / 5.0
D+
Value
B
Factor Score 3.4 / 5.0
Growth
D-
Factor Score 0.9 / 5.0
Profitability
D+
Factor Score 1.7 / 5.0
Momentum
F
Factor Score 0.4 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 0.0
EV / EBITDA -1.2
Rev Growth YoY -38.4%
Gross Margin N/M
Price Return 3M -94.7%
Price Return 12M -98.6%
Catalyst Signal 0.00
Market Cap $869.8K
TTM Revenue $679.0K
Price / Sales 1.3
ROE -164.5%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-15 B (3.4) D- (0.9) D+ (1.7) F (0.4) C+ (2.6) D+ (1.8)
2026-11-08 B (3.4) D- (0.9) D+ (1.7) D- (0.8) C+ (2.6) C- (1.9)
2026-11-01 B (3.4) D- (0.9) D+ (1.8) F (0.6) C+ (2.7) C- (1.9)
2026-10-25 B (3.3) D- (0.9) D+ (1.8) D- (0.9) C+ (2.6) C- (1.9)
2026-10-18 B (3.2) D- (0.9) D+ (1.8) D (1.3) C+ (2.6) C- (1.9)
Page 1 of 4